P2.11. Synergistic Co-Targeting Of MYC And KRAS In Lung Cancer By Novel Ligand-Directed Inverted Chimeric RNAi Molecules - PDF(Abstract)
Back to course
Pdf Summary
Asset Subtitle
Yogitha Chareddy
Meta Tag
Speaker Yogitha Chareddy
Topic Metastatic NSCLC: Targeted Therapy - KRAS/MET
KRAS gene
MYC gene
lung cancer
ligand-conjugated oligonucleotide-based strategy
non-small cell lung cancer (NSCLC)
mutant-specific small-molecule inhibitors
chimeric RNAi molecules
EGFR-targeting ligand
synergistic anti-cancer effects
Powered By